Aiden Abidov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aiden Abidov has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Omar Chehab
Division of Cardiology, Department of Medicine, Johns Hopkins University , 600 North Wolfe Street, Baltimore, MD 21287
4 shared publications Ahmed Subahi
Wayne State University School of Medicine, United States
2 shared publicationsAlexandros Briasoulis
Division of Cardiology, Internal Medicine Department, University of Iowa, Iowa City
2 shared publications- Amjad Kanj
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
2 shared publications - Ashley Sullivan
Department of Emergency Medicine, Wayne State University School of Medicine, 6071 W. Outer Dr., Lourdes 447-D, Detroit, MI, 48235, USA
2 shared publications Emmanuel Akintoye
Wayne State University School of Medicine, United States
2 shared publications
Latest Publications
- 18 February 2025
- Published by Wiley in Echocardiography
- Vol. 42 (2) , e70111
Value of Advanced Cardiac CTA in Clinical Assessment of Hypertrophic Cardiomyopathy: A Literature Review and Practical Implications
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac anomaly with a potentially unfavorable clinical outcome. The essential role of multimodality imaging in HCM is well recognized by major professional cardiac imaging societies and has been incorporated into the HCM clinical practice guidelines. Appropriate utilization of cardiac imaging tools is cardinal for accurate diagnosis and appropriate management for HCM patients to mitigate their lifelong risk of adverse events. Echocardiography is the imaging modality of choice for clinical diagnosis of HCM. Cardiac magnetic resonance (CMR) and coronary computed tomography angiogram (CCTA) offer complementary practical information for an inclusive evaluation in such patients. CCTA provides a thorough analysis of the cardiac anatomy and function that is paramount in HCM clinical decision‐making. This review summarizes the utility of CCTA in the clinical assessment of patients with HCM. It outlines the multi‐role of CCTA in HCM, including the quantification of cardiac parameters, myocardial tissue characterization, left ventricular (LV) functional analysis, the definition of cardiac and coronary arteries (CA) anatomy, and the provision of a roadmap for septal reduction therapies (SRT), mitral valve (MV) intervention, and atrial fibrillation (AF) ablation.
- 18 February 2025
- Published by Wiley in Echocardiography
- Vol. 42 (2) , e70111
Value of Advanced Cardiac CTA in Clinical Assessment of Hypertrophic Cardiomyopathy: A Literature Review and Practical Implications
Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac anomaly with a potentially unfavorable clinical outcome. The essential role of multimodality imaging in HCM is well recognized by major professional cardiac imaging societies and has been incorporated into the HCM clinical practice guidelines. Appropriate utilization of cardiac imaging tools is cardinal for accurate diagnosis and appropriate management for HCM patients to mitigate their lifelong risk of adverse events. Echocardiography is the imaging modality of choice for clinical diagnosis of HCM. Cardiac magnetic resonance (CMR) and coronary computed tomography angiogram (CCTA) offer complementary practical information for an inclusive evaluation in such patients. CCTA provides a thorough analysis of the cardiac anatomy and function that is paramount in HCM clinical decision‐making. This review summarizes the utility of CCTA in the clinical assessment of patients with HCM. It outlines the multi‐role of CCTA in HCM, including the quantification of cardiac parameters, myocardial tissue characterization, left ventricular (LV) functional analysis, the definition of cardiac and coronary arteries (CA) anatomy, and the provision of a roadmap for septal reduction therapies (SRT), mitral valve (MV) intervention, and atrial fibrillation (AF) ablation.
- Open Access
- 5 January 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (1) , 102846
Tongue Squamous Cell Carcinoma With Cardiac Metastases
- 5 January 2025
- Published by Elsevier in JACC: Case Reports
- Vol. 30 (1) , 102846
Open AccessTongue Squamous Cell Carcinoma With Cardiac Metastases
- 13 June 2024
- Published by Wiley in Echocardiography
- Vol. 41 (6) , e15863
Pulmonary pulse transit time: A promising marker in assessing early cardiopulmonary hemodynamic changes in patients with chronic obstructive pulmonary disease
- 13 June 2024
- Published by Wiley in Echocardiography
- Vol. 41 (6) , e15863
Pulmonary pulse transit time: A promising marker in assessing early cardiopulmonary hemodynamic changes in patients with chronic obstructive pulmonary disease
- 27 October 2021
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 28 (6) , 619-622
Hypertensive Emergency in Heart Failure: Trends, Risk factors and Outcomes from a Nationwide Analysis 2005–2014
Introduction Heart failure (HF) patients may be susceptible to complications of hypertensive emergency (HTNE). Large registries have found that these patients are not on optimal antihypertensive therapy. To date, little investigation has been done on HF patients with HTNE, and their clinical risk factors/outcomes have not been well defined. Methods We reviewed the National Inpatient Sample database to collect data on HF patient hospitalizations from 2005 to 2014. HF patients with and without a primary diagnosis of HTNE were included in the analysis. Risk factors and outcomes of HF patients with a primary diagnosis of HTNE were compared to those without HTNE. HF patients with a primary diagnosis of shock of any etiology were excluded. Results Of 8,265,792 patients hospitalized with HF, 39,170 (0.5%) had HTNE. There was a threefold increase in the incidence of HTNE in HF patients over a 10-year period. The increase was more evident in females, Blacks and those < 40 years of age. There was also an increasing trend in modifiable risk factors. HF patients with HTNE had significantly higher major in-hospital complications compared to those without HTNE. However, this association did not reflect an increase in short-term in-hospital mortality, irrespective of age. Conclusion HF patients with HTNE represent a unique population that requires a different approach to treatment. Further research is needed to identify barriers preventing adequate therapy of hypertension and other modifiable risk factors in HF patients and assess their effects on long-term outcomes.
- 27 October 2021
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 28 (6) , 619-622
Hypertensive Emergency in Heart Failure: Trends, Risk factors and Outcomes from a Nationwide Analysis 2005–2014
Introduction Heart failure (HF) patients may be susceptible to complications of hypertensive emergency (HTNE). Large registries have found that these patients are not on optimal antihypertensive therapy. To date, little investigation has been done on HF patients with HTNE, and their clinical risk factors/outcomes have not been well defined. Methods We reviewed the National Inpatient Sample database to collect data on HF patient hospitalizations from 2005 to 2014. HF patients with and without a primary diagnosis of HTNE were included in the analysis. Risk factors and outcomes of HF patients with a primary diagnosis of HTNE were compared to those without HTNE. HF patients with a primary diagnosis of shock of any etiology were excluded. Results Of 8,265,792 patients hospitalized with HF, 39,170 (0.5%) had HTNE. There was a threefold increase in the incidence of HTNE in HF patients over a 10-year period. The increase was more evident in females, Blacks and those < 40 years of age. There was also an increasing trend in modifiable risk factors. HF patients with HTNE had significantly higher major in-hospital complications compared to those without HTNE. However, this association did not reflect an increase in short-term in-hospital mortality, irrespective of age. Conclusion HF patients with HTNE represent a unique population that requires a different approach to treatment. Further research is needed to identify barriers preventing adequate therapy of hypertension and other modifiable risk factors in HF patients and assess their effects on long-term outcomes.
- Open Access
- 1 October 2021
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 5 (5) , 891-897
SARS-CoV-2 Viral Load and Myocardial Injury: Independent and Incremental Predictors of Adverse Outcome
- 1 October 2021
- Published by Elsevier in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
- Vol. 5 (5) , 891-897
Open AccessSARS-CoV-2 Viral Load and Myocardial Injury: Independent and Incremental Predictors of Adverse Outcome
- 1 February 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (2) , 182-193
Cardiovascular Effects of Medical Marijuana: A Systematic Review
- 1 February 2021
- Published by Elsevier in The American Journal of Medicine
- Vol. 134 (2) , 182-193
Cardiovascular Effects of Medical Marijuana: A Systematic Review
- 10 December 2020
- Published by Wiley in Echocardiography
- Vol. 38 (1) , 151-154
Unmasking pulmonary hypertension following tricuspid valve replacement
In this Viewpoint, we highlight a possible hemodynamic problem arising following tricuspid valve replacement (TVR) in patients with severe chronic tricuspid regurgitation, represented by “unmasking” of pulmonary hypertension (PH) following the surgery. We share an observation that should alert cardiologists to the fact that this increasingly utilized surgery is not risk free, and careful assessment of the right ventricular function and pulmonary circulation preoperatively is extremely important, especially in patients with preexisting risk factors for PH, since TVR may lead to a sudden increase in right ventricular afterload.
- 10 December 2020
- Published by Wiley in Echocardiography
- Vol. 38 (1) , 151-154
Unmasking pulmonary hypertension following tricuspid valve replacement
In this Viewpoint, we highlight a possible hemodynamic problem arising following tricuspid valve replacement (TVR) in patients with severe chronic tricuspid regurgitation, represented by “unmasking” of pulmonary hypertension (PH) following the surgery. We share an observation that should alert cardiologists to the fact that this increasingly utilized surgery is not risk free, and careful assessment of the right ventricular function and pulmonary circulation preoperatively is extremely important, especially in patients with preexisting risk factors for PH, since TVR may lead to a sudden increase in right ventricular afterload.
- Open Access
- 1 September 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (11) , 1812-1817
Giant Calcified Left Circumflex Coronary Artery Aneurysm With Complex Coronary-to–Left Ventricular Communication
- 1 September 2020
- Published by Elsevier in JACC: Case Reports
- Vol. 2 (11) , 1812-1817
Open AccessGiant Calcified Left Circumflex Coronary Artery Aneurysm With Complex Coronary-to–Left Ventricular Communication
- 1 September 2020
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 14 (5) , e82-e84
Utilization of coronary computed tomography angiogram in evaluation of left ventricular thrombus
- 1 September 2020
- Published by Elsevier in Journal of Cardiovascular Computed Tomography
- Vol. 14 (5) , e82-e84
Utilization of coronary computed tomography angiogram in evaluation of left ventricular thrombus